Escient Pharmaceuticals
San Diego, US · Founded 2017 · Delaware corporation · 5 known investors
Biotech
Founders & leadership
JK
JeenJoo KangDirector
RT
Robert TjianDirector
AB
Alain BaronExecutive Officer, Director
MB
Marcus BoehmExecutive Officer
AS
Andrew SchwabDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$60MraisedNov 2022 · 22 investors · BiotechnologyRule 506(b)
▶$60MraisedNov 2022 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter HirthDirector
- Charles ZukerDirector
- Kathleen Sereda GlaubDirector
- Jason HaflerDirector
- Kevin RaidyDirector
- Aaron MishelExecutive Officer
- Joshua GrassExecutive Officer, Director
- JeenJoo KangDirector
- Andrew SchwabDirector
- Marcus BoehmExecutive Officer
- Offering amount
- $120M
- Amount sold
- $60M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.8MraisedSep 2020 · 18 investors · BiotechnologyRule 506(b)
▶$38.8MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marcus BoehmExecutive Officer
- Charles ZukerDirector
- Kevin RaidyDirector
- Kathleen GlaubDirector
- Alain BaronExecutive Officer, Director
- Andrew SchwabDirector
- JeenJoo KangDirector
- Jason HaflerDirector
- Peter HirthDirector
- Offering amount
- $77.5M
- Amount sold
- $38.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 10 investors · BiotechnologyRule 506(b)
▶$10MraisedApr 2018 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JeenJoo KangDirector
- Robert TjianDirector
- Alain BaronExecutive Officer, Director
- Marcus BoehmExecutive Officer
- Andrew SchwabDirector
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.